Evidence map›Paper›PMID 29362859›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2018

Christos Sachpekidis, P Bäumer, K Kopka, B A Hadaschik, M Hohenfellner, A Kopp-Schneider, U Haberkorn, A Dimitrakopoulou-Strauss

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 41 citations in OpenAlex.

  1. PET/CT Identifies Pubic Melorheostosis with HighMolecular imaging and radionuclide therapy · 2026
    Article
  2. Article
  3. Comparison ofScientific reports · 2025
    Article
  4. Article
  5. Detecting and Locating the Site of Local Relapse UsingMolecular imaging and biology · 2023
    Article
  6. Imaging Techniques in Pharmacological Precision Medicine.Handbook of experimental pharmacology · 2023
    Article
  7. StagingEuropean journal of nuclear medicine and molecular imaging · 2022
    Article
  8. Transpathology: molecular imaging-based pathology.European journal of nuclear medicine and molecular imaging · 2021
    Review
  9. Article
  10. Parameters predicting [EJNMMI research · 2021
    Article
  11. Article
  12. Article
  13. Frontiers in oncology · 2021
    Article
  14. Article
  15. Comparison ofTranslational andrology and urology · 2020
    Article
  16. European journal of nuclear medicine and molecular imaging · 2020
    Article
  17. Dynamic patterns of [European journal of nuclear medicine and molecular imaging · 2020
    Article
  18. Review
  19. European journal of nuclear medicine and molecular imaging · 2018
    Article
  20. American journal of nuclear medicine and molecular imaging · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Christos SachpekidisClinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69210, Heidelberg, Germany. christos_saxpe@yahoo.gr.ORCID 0000-0001-8739-8741
P BäumerDepartment of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
K KopkaDivision of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany.
B A HadaschikDepartment of Urology, University Hospital Heidelberg, Heidelberg, Germany.
M HohenfellnerDepartment of Urology, University Hospital Heidelberg, Heidelberg, Germany.
A Kopp-SchneiderDepartment of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
U HaberkornClinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69210, Heidelberg, Germany.
A Dimitrakopoulou-StraussClinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69210, Heidelberg, Germany.
German Cancer Research Center · DEHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aims of this retrospective analysis were to compare

methodsIn total, 152 PET/CT scans from 140 patients were evaluated. Of these patients, 30 had previously untreated primary PC, and 110 had biochemical relapse after treatment of primary PC. All patients underwent dynamic PET/CT scanning of the pelvis and lower abdomen as well as whole-body PET/CT with

resultsIn total, 168

conclusion

Indexed as

Positron Emission Tomography Computed TomographyAdultAgedAged, 80 and overBone NeoplasmsHumansMaleMiddle AgedNeoplasm GradingProstatic NeoplasmsRetrospective Studies68Ga-PSMA PET/CTProstate cancer bone metastasesPSASUVTwo-tissue compartment model

Identifiers

PMID29362859
OpenAlexW2788389042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.